Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Burns Pipeline Review, H2 2016: 17 Companies & 29 Molecules - Research and Markets

Research and Markets
Posted on: 06 Oct 16

Research and Markets has announced the addition of the "Burns - Pipeline Review, H2 2016" report to their offering.

Burns pipeline therapeutics constitutes close to 29 molecules. Out of which approximately 27 molecules are developed by Companies and remaining by the Universities

Institutes. The molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 3, 2, 11, 5 and 4 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 1 and 1 molecules, respectively.

Burns - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Burns, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews of key players involved in therapeutic development for Burns and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Burns Overview
  3. Therapeutics Development
  4. Pipeline Products for Burns - Overview
  5. Pipeline Products for Burns - Comparative Analysis
  6. Burns - Therapeutics under Development by Companies
  7. Burns - Therapeutics under Investigation by Universities/Institutes
  8. Burns Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Burns - Products under Development by Companies
  13. Burns - Products under Investigation by Universities/Institutes
  14. Burns - Companies Involved in Therapeutics Development
  • Adocia
  • AlgiPharma AS
  • Amarantus Bioscience Holdings, Inc.
  • American Gene Technologies International Inc.
  • Biogenomics Limited
  • CytoTools AG
  • Destiny Pharma Limited
  • Lakewood-Amedex Inc
  • Madam Therapeutics B.V.
  • MediWound Ltd.
  • Mitochon Pharmaceuticals, Inc.
  • Phosphagenics Limited
  • Se-cure Pharmaceuticals Ltd.
  • Sinclair Pharma Plc
  • Stratatech Corporation
  • Tissue Therapies Limited
  • USV Pvt Ltd

For more information about this report visit

View source version on

Business Wire

Last updated on: 06/10/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.